|
HS Code |
420539 |
| Product Name | 3-Fluoro-DL-Phenylalanine |
| Cas Number | 453-81-2 |
| Molecular Formula | C9H10FNO2 |
| Molecular Weight | 183.18 g/mol |
| Appearance | White to off-white powder |
| Purity | Typically ≥98% |
| Melting Point | 265-267°C (dec.) |
| Solubility In Water | Slightly soluble |
| Storage Temperature | 2-8°C |
| Synonyms | DL-3-Fluorophenylalanine |
| Iupac Name | 2-amino-3-(3-fluorophenyl)propanoic acid |
| Smiles | C1=CC(=CC(=C1)F)CC(C(=O)O)N |
| Optical Activity | Racemic (DL mixture) |
| Usage | Amino acid analog for research |
As an accredited 3-Fluoro-Dl-Phenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle labeled "3-Fluoro-Dl-Phenylalanine, 5g," with hazard symbols, CAS number, lot number, and manufacturer details. |
| Shipping | 3-Fluoro-Dl-Phenylalanine is shipped in tightly sealed, chemical-resistant containers to prevent contamination and moisture exposure. It is handled as a non-hazardous substance under normal conditions. Shipping complies with local and international regulations, including proper labeling and temperature control if required, ensuring safe and secure delivery to the destination. |
| Storage | 3-Fluoro-DL-Phenylalanine should be stored in a tightly sealed container, protected from light, moisture, and incompatible materials. Keep the chemical in a cool, dry, and well-ventilated area, ideally at 2–8°C (refrigerated conditions). Avoid exposure to ignition sources and strong oxidizing agents. Ensure proper labeling and restrict access to authorized personnel only. Use appropriate personal protective equipment when handling. |
Applications of 3-Fluoro-Dl-Phenylalanine in Industrial Manufacturing3-Fluoro-Dl-Phenylalanine serves as a specialized building block in select industrial sectors, supporting complex synthesis and manufacturing processes that demand strict compliance and traceability. Below, we detail verified downstream applications where our 3-Fluoro-Dl-Phenylalanine integrates into established production workflows, noting product-specific industry standards, incorporation levels, process integration stages, and finished goods as realized in the international market. 1. Active Pharmaceutical Ingredient (API) Intermediate SynthesisPharmaceutical manufacturers utilize this non-natural amino acid chiefly as an intermediate in chiral API production, particularly in routes where fluorinated aromatic analogues impart desired pharmacokinetic properties. Chemists insert this molecule during multi-step syntheses to provide metabolic stabilization or modulate target interactions, frequently in small-molecule CNS and oncology pipeline projects, with full traceability under regulatory frameworks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Peptide Therapeutics DevelopmentResearch-driven peptide companies formulate this molecule to enhance structural stability or tailor bioactivity of synthetic peptides. Inclusion of a fluorinated aromatic ring can mitigate degradation or modulate receptor selectivity in targeted peptides for autoimmune, CNS, or metabolic indications. Most often, process control and risk management systems oversee preparation of such building blocks for preclinical and clinical batches. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Radiolabeled Imaging Agent SynthesisMolecular imaging and diagnostic reagent companies deploy the fluorinated amino acid as a direct precursor for PET imaging compound production, where the aromatic fluorine is a site for isotopic exchange or tracer attachment. Strict QC and radioisotope handling standards govern this application throughout the synthesis and formulation of PET probe batches for clinical imaging studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chiral Analytical Standards and Reference MaterialsManufacturers of certified reference materials utilize this specialty amino acid as a calibration and control standard for enantioselective HPLC and LC-MS method development. Laboratories implementing regulated bioanalysis, or monitoring chiral switch candidates, rely on traceable lots that match high-purity analytical standards and appropriate documentation for international trade and regulatory acceptance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Fluoro-Dl-Phenylalanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer focused on research-grade amino acids, we’ve followed the development and applications of 3-Fluoro-DL-Phenylalanine closely over the years. This compound, known for a single fluorine atom substituted on the aromatic ring, provides users with key advantages in synthetic biology, medicinal chemistry, and molecular diagnostics. Unlike standard phenylalanine, this analog packs a distinctive punch. Fluorine’s small size and electronegativity don’t just change the way the molecule interacts with enzymes and receptors—they open up a range of uses for those looking to explore structure–activity relationships or engineer new protein behaviors.
Our in-house production line outputs 3-Fluoro-DL-Phenylalanine at consistently high purity, supporting strict analytical demands. Typically, we target purity levels above 98% through recrystallization and rigorous HPLC assessment, which translates to reliable, repeatable results in chemical and biological systems. As a manufacturer, we see firsthand the difference that quality makes during downstream reactions. Low-impurity batches simply mean researchers can spend less time troubleshooting side effects, and more time innovating.
The white, crystalline appearance and solid stability of our 3-Fluoro-DL-Phenylalanine provide easy handling in both small-scale research and semi-large synthesis. This material shows limited hygroscopicity, so there’s less concern about moisture uptake compared to some other amino acid analogs. Packaging follows rigorous standards, minimizing contamination during filling or shipment. In our facilities, automated bottling and an inline nitrogen purging system further protect product integrity.
We’ve worked with a broad catalog of aromatic amino acid derivatives, and 3-Fluoro-DL-Phenylalanine stands out in several ways. The introduction of fluorine at the 3-position on the phenyl ring yields altered electronic effects while keeping steric hindrance low enough for many enzymes and synthetic pathways. Compared to hydroxy- or methyl-substituted phenylalanines, the fluoro analog typically shows different patterns of metabolic stability, resistance to oxidative degradation, and altered substrate affinities in both enzymatic assays and in vivo studies.
Fluoro-phenylalanine analogs, especially the 3-fluoro variant, have proven more resistant to certain metabolic breakdown routes—those seeking to prolong the metabolic half-life of a probe or peptide benefit from these characteristics. In contrast, heavier or more electron-donating substitutions on the phenyl ring can introduce unpredictable interactions with transport proteins, which often shows up as batch-to-batch irreproducibility or biological noise. Our experience combining substrate testing with LC-MS validation makes us acutely aware of how fluorination offers a sweet-spot: enough change to be trackable, without fully disrupting normal molecular recognition.
Many of our regular clients, especially in academia and the pharmaceutical sector, use 3-Fluoro-DL-Phenylalanine as both a metabolic probe and a non-canonical amino acid for protein engineering. Its incorporation into peptides and proteins—either in vitro through chemical synthesis, or in vivo through auxotrophic expression or reengineered tRNA/synthetase pairs—facilitates deep study of enzyme-substrate selectivity, metabolic pathways, and protein–ligand binding.
One critical insight from our collaborations pertains to site-specific mutagenesis. Substituting a hydrogen in the phenylalanine side chain with fluorine has allowed researchers to distinguish subtle π-stacking, cation–π, and hydrophobic interactions in folded proteins and receptor-ligand systems. Compared to other isotopically labeled or halogenated derivatives, the 3-fluoro analog consistently delivers a balance between traceability and perturbation. In NMR spectroscopy and crystallography, the presence of fluorine aids signal visibility without excessive electron density distortion, supporting both quantitative kinetics and qualitative structure elucidation.
Fluorinated amino acids, including 3-Fluoro-DL-Phenylalanine, are widely adopted in modern drug design because they influence biological activity and metabolic fate in ways that classical substitutions do not. Med chem teams leverage our batches in lead optimization campaigns. The inclusion of a fluorine atom frequently changes the electrostatic properties of a binding pocket, tuning both potency and selectivity. In peptide drugs, resistance to enzymatic cleavage often correlates with increased in vivo persistence and bioavailability. Chemists have found that incorporating our 3-fluoro analog enables new SAR (structure–activity relationship) insights, especially when differentiating between receptor subtypes or allosteric modulator sites.
Scaling up any specialty amino acid brings its own headaches—the challenge grows with delicate substitutions like fluorine. As manufacturers, we monitor every synthetic stage, from protected precursor selection through deprotection, crystallization, and analytical release. Our purification process, honed over years of continuous optimization, avoids by-products that can mask or mimic the desired activity in biological assays. We routinely run validation reactions both internally and in collaboration with external labs, confirming that the functionalization occurs precisely at the 3-position.
Chemical stability often poses concerns with substituted aromatic amino acids, but 3-Fluoro-DL-Phenylalanine maintains shelf-life well under standard storage. Routine batch analytics confirm minimal change in melting point, solubility, or appearance, which gives us and our partners confidence in reordering over time.
We regularly supply 3-Fluoro-DL-Phenylalanine to teams focused on mass spectrometry calibration, labeling studies, and metabolomics. The fluorine tag creates a signature mass shift, allowing it to stand out from endogenous phenylalanine during isotope dilution or tracer dosing. In chiral analysis, the racemic DL-form provides the advantage of controlling for both enantiomers in systems where stereospecificity impacts data interpretation. Our clients have published on using this analog to quantify turnover in multi-step enzyme cascades and map out shunt pathways that remain invisible using traditional labeling approaches.
Standard amino acids rarely offer such analytical leverage—this is a core reason why demand for fluoro-derivatives remains steady, even as newer labeling methodologies emerge. The cost per analytical insight decreases when researchers start with high-purity, fully characterized input, which aligns with our mission of supporting reproducible, meaningful experimentation.
Production of halogenated amino acids calls for greater vigilance over potential by-products and material handling. Our facilities limit environmental discharge and maintain air scrubbing to curtail worker exposure to volatile fluorinated species. Given that 3-Fluoro-DL-Phenylalanine shares much of the biochemistry of standard amino acids, its toxicity profile remains low, though prudent lab protocols for dust control and personal protective equipment always remain standard operating procedure.
Over the past decade, users have raised questions about the long-term fate of fluorinated compounds. The robust C–F bond means increased stability, but it also implies slower biodegradation. Our technical team explores greener synthetic routes and post-use handling recommendations, including recovery or catalytic decomposition of unused material. Maintaining open dialogue with our partners about end-of-life management reflects our commitment beyond just batch delivery.
Global supply chain shocks, geopolitical events, and transport disruptions have led to sporadic shortages in specialty biochemicals. We’ve weathered those disruptions because we manufacture 3-Fluoro-DL-Phenylalanine entirely on-site, without relying on uncertain imports of precursor materials. Our raw material sourcing utilizes longstanding, audited relationships with regional producers. Automated QA protocols, batch-specific documentation, and regular audits by pharmaceutical and biotech clients keep us accountable.
Rather than relying on third-party testing, we conduct each lot release with our own HPLC, NMR, IR, and, when necessary, chiral GC verification. Unused stock from every batch remains archived, creating a reliable trail for retrospective analysis or troubleshooting. Those who’ve dealt with spotty, third-country origin chemical supply appreciate the difference a vertically integrated, directly accountable manufacturer makes.
Feedback from researchers, medicinal chemists, and biotech startups has pushed us to refine both formulation and service. Some needed denser documentation packages for regulatory files; others requested custom particle sizing for high-throughput screening automation. We listen because we share the same commitment to scientific impact.
Cross-departmental collaborations between our manufacturing chemists and analytical specialists have led to fewer out-of-specification events and faster troubleshooting. By producing and testing at the source, not only do lead times stay short, but complicated supply chain management headaches disappear. Consistency over time gives research programs the confidence to invest in larger studies or new drug modalities based on 3-Fluoro-DL-Phenylalanine.
The scientific landscape continues to evolve, and one area of active exploration is the expansion beyond DL-isomers. Our R&D chemists keep up with protocols for resolving the L- and D-enantiomers, which carry implications for stereospecific biochemistry, receptor selectivity, and even origins-of-life studies. With more projects targeting site-specific fluorination in therapeutics and imaging agents, the demand for enantiopure materials will only rise. We work with clients to develop custom resolutions or isotopically labeled variants when new projects demand it.
Meanwhile, regulatory environments and end-use documentation grow more complex. This trend echoes throughout the chemical industry: Downstream users want to see clear traceability, impurity profiles, and sustainability claims. Rather than shifting responsibility onto secondary suppliers, we operate transparently, supplying batch-level certification and conducting in-house testing tailored to each customer’s application.
Producing 3-Fluoro-DL-Phenylalanine goes beyond routine synthesis. The true impact comes from partnering with scientists at the cutting edge—from probing the inner workings of enzymes, to optimizing drugs fighting today’s toughest diseases. Our role involves both delivering reliable raw material and working as technical partners when unexpected challenges arise. This means staying current with scientific advances and routinely reinvesting in analytical and production technology.
In every batch, we see a story—of collaboration, shared troubleshooting, and discovery. Whether you are mapping a metabolic pathway, designing a new class of peptide therapeutics, or developing advanced diagnostic reagents, our hands-on manufacturing experience ensures you have the right foundation. By being both producer and partner, we strive to catalyze breakthroughs across academic, biotechnology, and pharmaceutical frontiers with every gram of 3-Fluoro-DL-Phenylalanine we supply.